Paragard Injury Lawyers To Meet With MDL Court For Monthly Status Conferences Through End of Year

The U.S. District Judge presiding over all Paragard IUD injury lawsuits filed throughout the federal court system, which were recently consolidated for pretrial proceedings, has scheduled a series of status conferences throughout the rest of the year.

There are currently more than 200 product liability lawsuits brought in U.S. District Courts nationwide, each involving allegations that women suffered painful and debilitating Paragard IUD complications when the small birth control implant fractured or broke as doctors attempted to remove it. However, as Paragard injury lawyers continue to review and file cases in the coming months and years, it is ultimately expected that several thousand claims will be included in the litigation.

Paragard IUD is a T-shaped plastic device wrapped in copper, which is placed in the uterus to provide women long-acting protection against pregnancy for up to ten years. However, the procedure is designed to be reversible, allowing doctors to remove the IUD during an out-patient office procedure when they no longer want the birth control.

Given common questions of fact and law raised in complaints filed in U.S. District Courts nationwide, consolidated pretrial proceedings were established in December 2020, transferring all pending and new cases filed throughout the federal court system to the U.S. District Court for the Northern District of Georgia, for coordinated discovery and pretrial proceedings before U.S. District Judge Leigh Martin.

On June 15, Judge May issued a court order (PDF), which lays out a schedule of monthly status conferences to be held through out the year. Those conference dates include July 13, August 20, September 21, October 19, November 16 and December 14.

The order calls for parties to submit proposed agendas for the conferences at least three business days prior to those dates. In addition, the parties should submit any issues which require additional explanation within the same timeframe.

As part of the management of the litigation, it is expected that Judge May will establish a “bellwether” process, where a small group of representative claims will be prepared for early trial dates to help gauge how juries may respond to certain evidence and testimony that will be presented throughout other cases.

While the outcome for these early trials would not be binding on other plaintiffs, they may facilitate negotiations to resolve the litigation and avoid the need for hundreds of cases to go before federal juries nationwide in future years.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Plaintiffs are asking a federal panel to consolidate a growing number of spinal cord stimulator lawsuits against Abbott and Boston Scientific, alleging defective design changes caused lead fractures, device failures and neurological injuries nationwide.
A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks.
A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.